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ABSTRACT: Previous research evaluated a labora-
tory strain of Bacillus licheniformis (BL) in a model 
swine epithelium and found it exerted antiinflammato-
ry effects on Salmonella enterica serovar Typhimurium 
(Sal)-induced secretion of IL-8. The current investiga-
tion evaluated the antiinflammatory actions of Bacil-
lus bacteria available commercially as feed additives for 
the swine industry. Three isolates were obtained from 
the product, 2 Bacillus subtilis (BS1 and BS3) and 1 
BL (BL2). Swine jejunal epithelial IPEC-J2 cells were 
seeded into wells on permeable membrane supports and 
allowed to form confluent monolayers. Treatments in-
cluded apical pretreatment with BL, BS1, BL2, or BS3 
for 17 h without Sal, and the same Bacillus treatments 
but with 108 cfu of Sal added in the final hour of Ba-
cillus incubation. Two additional treatments included 
negative control wells receiving no bacteria (control) 
and positive control wells receiving only Sal (10 to-
tal treatments). After bacterial incubation, wells were 
washed and fresh medium containing gentamicin was 
added. Cells were incubated for an additional 5 h, af-
ter which apical and basolateral media were recovered 
for determination of IL-8 and bacitracin. In addition, 
inserts with epithelial cells that had received Sal were 
lysed and lysates were cultured to determine treatment 
effects on Sal invasion. Exposure to Sal alone provoked 
an increase in IL-8 secretion from IPEC-J2 cells com-
pared with control wells (P < 0.001 for both the api-
cal and basolateral directions). Pretreatment with each 
Bacillus isolate followed by challenge with Sal reduced 
Sal-induced IL-8 secretion in both the apical and ba-
solateral compartments compared with wells receiving 
only Sal (P < 0.001; except for BS3 apical, P < 0.01). 
The residual presence of bacitracin could be detected 
only in BL2 and BL2+Sal. Fewer Sal colonies could be 
cultured from lysates of BL2+Sal than from the Sal, 
BS1+Sal, and BS3+Sal treatments (P < 0.001). Re-
sults indicate that B. subtilis and BL have the ability to 
intervene in secretion of the neutrophil chemoattractant 
IL-8 from swine intestinal epithelial cells. This effect on 
chemokine secretion by gastrointestinal epithelial cells 
in vitro could not be explained solely by reduced inva-
sion of epithelial cells by Sal.
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INTRODUCTION
The growth response of nursery pigs to in-feed anti-
biotics is well documented (Dritz et al., 2002). To date, 
no single additive or class of additives has been identi-
fied to replace the growth response of nursery pigs to 
in-feed antibiotics. However, the search for nonantibi-
otic replacements continues, with the direct-fed micro-
bials representing a significant portion of that search. 
In general, evaluation of direct-fed microbials, at times 
referred to as probiotics, has been largely empirical. 
Little is actually known to suggest how direct-fed mi-
crobials may interact with enterocytes in the presence 
of pathogenic organisms that are presumably controlled 
(to some extent) by growth-promoting quantities of di-
etary antibiotics. Bacillus spp. represent a collection 
of species that may have potential as direct-fed micro-
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bials. Bacillus bacteria are attractive because of their 
well-established ability to sporulate and their tendency 
to produce secondary metabolites (US Environmental 
Protection Agency, 1997a,b). To that end, our labora-
tory previously evaluated a laboratory strain of Ba-
cillus licheniformis (BL) in a model swine epithelium 
and found it to intervene significantly in Salmonella 
enterica serovar Typhimurium (Sal)-induced secretion 
of IL-8 from gut epithelial cells (Skjolaas et al., 2007). 
Additional preliminary results suggested that the anti-
inflammatory effects of BL were time dependent (God-
sey et al., 2007). The current investigation was under-
taken to further evaluate the antiinflammatory actions 
of Bacillus spp. in a model swine gut epithelium. We 
specifically sought to evaluate these effects using Bacil-
lus bacteria available commercially as direct-fed micro-
bial feed additives for the swine industry.
MATERIALS AND METHODS
Animal Care and Use Committee approval was not 
obtained for this study because no animals were used.
The aim of this study was to investigate the interac-
tion of Bacillus bacteria and Sal in immune or inflam-
matory signaling from swine intestinal epithelial cells. 
Our previous investigation was limited to a laboratory 
strain of BL (Skjolaas et al., 2007). To gain access to 
Bacillus bacteria of relevance to the swine industry, we 
isolated strains from a commercial product (BioPlus 
2B, Chr. Hansen, Milwaukee, WI) for the current stud-
ies.
Bacterial Isolation
A sample of the commercial feed additive (25 g) was 
solubilized in 225 mL of sterile water and mixed. A 
1-mL quantity of the solution was then diluted in 9 mL 
of trypticase soy broth (TSB; MP Biomedicals LLC, 
Solon, OH). After an overnight incubation at 37°C, 
a trypticase soy agar (TSA; MP Biomedicals) plate 
was prepared using the broth and incubated overnight. 
Three different types of colonies were isolated. Colonies 
were forwarded to a commercial laboratory for identifi-
cation (Silliker Inc., St. Louis, MO). Specimens 1 and 3 
were identified as Bacillus subtilis (hereafter, BS1 and 
BS3, respectively). Specimen 2 was identified as BL 
(hereafter, BL2).
The Sal and the BL isolates used for additional treat-
ments were the same isolates used previously in our 
laboratory (Skjolaas et al., 2007). In brief, the Sal was 
isolated from a clinical case of swine enteric disease and 
the BL isolate was a laboratory strain obtained com-
mercially [American Type Culture Collection (ATCC), 
Manassas, VA].
Growth Curves
The growth behavior of bacterial isolates was impor-
tant in the design and execution of the experiment, 
particularly the growth of sufficient numbers of Bacil-
lus bacteria to distribute among treatments. Growth 
curves were established for each bacterial isolate in 
TSB. For this purpose, the absorbance of the broth at 
600 nm was measured, followed by a standard bacte-
rial plate count. After an overnight incubation at 37°C, 
colonies were counted and the bacterial population was 
estimated.
Bacterial Sensitivity
The sensitivity of the bacteria to common antibiotics 
was assessed using a microplate assay. Bacteria were 
cultured on TSA and incubated overnight at 37°C. 
Three to 5 colonies were then picked and placed in 
distilled water to obtain a turbidity of 0.5 McFarland 
turbidity standard (108 cfu). A 100-μL quantity of the 
suspension was added to a 9-mL tube of Mueller-Hin-
ton broth, and 50 μL of the final solution was added 
in each well of the microplate containing antibiotics 
at various dilutions. The plates were incubated for 24 
h at 37°C. The smallest antibiotic concentration that 
completely inhibited visible growth was considered to 
be the minimum inhibitory concentration. Qualitative 
data concerning antibiotic sensitivity were used to en-
sure bacteria cultured out of epithelial cells were Sal 
rather than one of the Bacillus spp.
Culture of Epithelial Cells
The swine jejunal epithelial cell line, IPEC-J2, was 
used to assess the interaction of Sal and the various Ba-
cillus isolates (Rhoads et al., 1994). Culture conditions 
were identical to those described previously (Skjolaas 
et al., 2006, 2007), except that IPEC-J2 cells (passages 
61 to 70) were cultured in 24-mm, 6-well Costar Snap-
wells (Corning Inc., Corning, NY) for exactly 7 d before 
executing the experiment.
Exposure of IPEC-J2 Cells to Bacteria
Twenty-four hours before the beginning of the ex-
periment, confluent IPEC-J2 cells were washed twice 
with PBS and fresh antibiotic-free medium was added. 
Bacillus bacteria were grown on TSB to obtain the re-
quired concentration.
Design of the bacterial exposure of epithelial cells 
was patterned after our previously published study 
(Skjo laas et al., 2007). There were 10 treatments, and 
this required each replicate of the experiment to oc-
cupy 2 culture plates. Eight of the 10 treatments re-
quired preexposure of IPEC-J2 in the apical chamber 
to a 17-h incubation with Bacillus isolates (108 cfu/
well). There were 4 Bacillus isolates, 3 of which were 
from the commercial product (BS1, BL2, and BS3) and 
1 of which was the ATCC strain (BL) used previously 
(Skjolaas et al., 2007). After 16 h had elapsed, one-half 
the wells containing Bacillus bacteria were treated api-
cally with 108 cfu of Sal and the other one-half received 
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a similar volume of sterile culture media. To recap, the 
8 treatment combinations were BL, BS1, BL2, and BS3 
without and with Sal coculture (BL+Sal, BS1+Sal, 
BL2+Sal, and BS3+Sal, respectively). The other 2 (of 
10 total) treatments were negative control wells receiv-
ing no bacteria (Con) and positive control wells receiv-
ing only Sal for 1 h. Each run of the experiment was 
conducted on 4 separate dates. Within each run, there 
were 3 replicate wells for each treatment.
After the 1-h incubation after addition of Sal, all 
wells were washed twice by overflooding of PBS to re-
move the extracellular bacteria. New growth medium 
containing 50 μg/mL of gentamicin (Gibco, Grand Is-
land, NY) was added to both the apical and basolateral 
wells. Plates were returned to the incubator for an ad-
ditional 5 h. Finally, the media from both apical and 
basolateral compartments were collected and stored for 
later IL-8 determination by ELISA as described previ-
ously (Skjolaas et al., 2006, 2007). An aliquot of the 
medium was also used to determine concentration of 
bacitracin (described in detail below).
Sal Invasion into IPEC-J2 Epithelial Cells
After removal of the media, inserts containing IP-
EC-J2 cells that had received treatment with Sal were 
washed twice with PBS, placed in new plates, and 
treated with 1 mL of 0.1% Triton X-100. The Triton 
X-100 solution was pipetted up and down to disrupt the 
epithelial cells thoroughly. Dilutions of the cell lysate 
were then applied to TSA plates that contained 250 
μg/mL of sulfadimethoxine. All Bacillus isolates had 
previously been determined to be sensitive to this anti-
biotic, whereas our Sal isolate was not. After an over-
night incubation at 37°C, colonies were counted and the 
number of colony-forming units of Sal per milliliter of 
IPEC-J2 lysate was determined.
Bacitracin Assay
Liquid chromatography coupled with electrospray-
ionization mass spectrometry (LCMS) was used to 
determine bacitracin production by the various Bacil-
lus bacteria used in the experiment. Commercial baci-
tracin was purchased from Sigma-Aldrich (Vetranal, 
analytical standard, Riedel-deHaen, Sigma-Aldrich, St. 
Louis, MO). Bacitracin standard solutions were pre-
pared by dilution of the commercial bacitracin in Dul-
becco’s modified Eagle’s medium/F12 growth medium 
(with gentamicin) at the concentrations of 50, 100, 500, 
1,000, 5,000, and 10,000 ng/mL. Samples (apical and 
basolateral media) were thawed and mixed thoroughly. 
Samples and standards were deproteinized by mixing 
100 μL of media with 200 μL of methanol (100%). The 
mixtures were again mixed well and centrifuged for 5 
min at maximum speed (16,100 × g at 4°C). A 200-μL 
quantity of the supernatant was then transferred to in-
jection vials for LCMS analysis.
The assay was optimized for bacitracin A only con-
sidering that bacitracin A is the predominant form of 
bacitracin produced (Konz et al., 1997). Chromato-
graphic separation was performed on a Supelco Discov-
ery C8 column (50 × 2.1 mm × 5 μM; Sigma-Aldrich). 
The mobile phase was a mixture of acetonitrile (A) and 
0.1% formic acid (B), and was delivered at a flow rate 
of 0.4 mL/min under a gradient elution program (0 to 
3 min, 5% A:95% B; 3 to 5 min, 30% A:70% B; 5 to 6 
min, 5% A:95% B; 6 min to the end, 5% A:95% B) at 
room temperature. A delay was observed between each 
injection to restore the initial conditions. The quali-
fying and quantifying ion mass-to-charge ratios (m/z) 
used in the mass spectrometry interface were, respec-
tively, 475.1 and 199.2. Settings, data acquisition, and 
processing were monitored by the software package 
Analyst version 1.5 (Applied Biosystems, Foster City, 
CA). The time of retention of bacitracin was approxi-
mately 4 min. The results were expressed as counts per 
second and were converted to nanograms of bacitracin 
per milliliter of media, and then further converted to 
nanograms per well.
Sal Sensitivity to Bacitracin
The sensitivity of Sal to bacitracin was established 
by a microdilution assay following the guidance of the 
Clinical and Laboratory Standards Institute (Wayne, 
PA). The commercial bacitracin was diluted 1:2 to cre-
ate a dilution range from 39 to 20,000 ng/mL and 0.05 
mL of each dilution was added into the wells of the 
microplate. Salmonella Typhimurium was cultured in 
Mueller Hinton cation-adjusted media (BD Diagnostic 
Systems, Franklin Lakes, NJ). The broth concentration 
was adjusted to 5 × 105 cfu/mL and 0.05 mL of the 
broth was added to the various concentrations of baci-
tracin in the microplate. Plates were incubated for 18 h 
and were then read at 590 nm.
Statistical Analyses
Apical and basolateral concentrations of IL-8 were 
converted to nanograms per well to account for the dif-
ference in volume of the apical (1.5 mL) vs. the baso-
lateral (2.6 mL) chamber. Concentrations of IL-8 in the 
apical and basolateral compartments were analyzed us-
ing the MIXED procedure (SAS Inst. Inc., Cary, NC). 
The model included the fixed effects of treatment, se-
cretion direction (apical or basolateral), and their inter-
action. Day was included in the model as a random ef-
fect. The MIXED procedure was also used to determine 
treatment effects for Sal invasion into IPEC-J2 epithe-
lial cells. In this case, treatment was the sole source 
of variation in the model. To ensure normality of the 
data, raw colony-forming unit values were square root 
transformed. Means (and SEM) were back transformed 
for presentation of the data. The bacitracin data were 
analyzed using the MIXED procedure with treatment 
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(with or without Sal), secretion direction, and their 
interaction in the model. All means are least squares 
means ± SEM. Bars depicted in the figures generally 
represent the means of 12 observations. Technical dif-
ficulties prevented inclusion of the Sal invasion assay 
data from one run. Therefore, those means represent 
9 observations. Comparisons of means were conducted 
only if a main effect or interaction was found to be sig-
nificant (P < 0.05) in the model. Means were declared 
statistically different at P < 0.05.
RESULTS
Identification of Bacterial Specimens  
from Commercial Product
The 3 different colonies recovered from the sample 
were sent to an accredited testing laboratory for mi-
crobiological and molecular (16S rRNA) analyses. The 
rRNA derived for the bacterial samples were matched 
with the library sequence database to find the clos-
est phylogenetic neighbors. None of the genetic profiles 
showed complete similarity with the library database. 
Specimens 1 (BS1) and 3 (BS3) had similarity scores 
with Bacillus subtilis subtilis (ATCC 6051) of 99.93 and 
99.99%, respectively (Table 1), and specimen 2 (BL2) 
was similar to BL at 98.1%.
The precise alignments of each specimen, with its 
closest match, were then analyzed and the results are 
summarized in Table 2. The base differences that occur 
at the beginning (0 to 100) or at the end (400 to 500) of 
the sequence may be due to anomalies in the promoter 
attachment and have to be considered with caution. 
The differences observed in the interior of the sequence 
are more likely to be accurate. Both the BS1 and BS3 
specimens exhibited 2 base differences compared with 
B. subtilis subtilis (ATCC 6051). In contrast, BL2 had 
a greater number of total mismatches (12) when com-
pared with the BL from the library. However, when 
looking at the alignment, many of these mismatches oc-
curred at the beginning and end of the sequence (base 
numbers 0, 1, 28, 31, 47, 49, 52, and 439).
All phylogenetic analyses clearly assigned the bac-
teria to the Bacillus genus. Specimens BS1 and BS3 
were more precisely identified as part of the B. subtilis 
spp. and BL2 was identified as a member of the BL 
species.
Table 1. Sample rRNA sequence comparison of specimens obtained from a commercial product with sequences in 
a reference library1 
Library database
Specimen 1 Specimen 2 Specimen 3
Match, % Mismatches Match, % Mismatches Match, % Mismatches
Bacillus subtilis subtilis (ATCC 6051)2 99.93 2 98.1 12 99.99 2
Bacillus mojavensis 99.71 3 98.36 11 99.73 3
Bacillus subtilis spizizenii (ATCC 6633) 99.65 3 98.02 13 99.6 3
B. subtilis spizizenii (DSM 15029)3 99.50 4 98.18 12 99.59 4
Bacillus atrophaeus 99.23 5 97.63 15 99.39 5
Bacillus amyloliquefaciens 99.07 7 97.43 16 99.26 7
Bacillus vallismortis 99.05 8 97.52 16 99.19 8
Bacillus licheniformis 97.41 15 98.62 12 97.18 15
Bacillus sonorensis 96.86 17 98.50 12 96.59 17
Bacillus oleronius 94.65 28 93.35 34 94.16 28
1MicroSEQ bacterial library from Applied Biosystems (Foster City, CA; AB_Bacterial500Lib_2.0).
2ATCC = American Type Culture Collection (Manassas, VA).
3DSM = Deutsche Sammlung von Mikroorganismen und Zellkulturen (Braunschweig, Germany).
Table 2. Location of mismatches of specimens obtained from a commercial product compared with reference se-
quences1 
Item
Base number
0 1 28 31 47 49 52 138 159 175 239 241 257 422 439
Specimen 1 R Y
 Bacillus subtilis subtilis (ATCC 6051)2 A T
Specimen 2 R W A T G T Y R T T A T
 Bacillus licheniformis G T C C T G C G G C G Y
Specimen 3 W R
 B. subtilis subtilis (ATCC 6051) T A
1The base number, in the top row, corresponds to the base position where a mismatch was observed. A = adenine; T = thymine; G = guanine; 
C = cytosine; R = A or G; W = A or T; Y = C or T.
2ATCC = American Type Culture Collection (Manassas, VA).
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IL-8
In the absence of Bacillus coculture, exposure to Sal 
alone provoked an increase in IL-8 secretion from IPEC-
J2 cells (Figure 1) compared with Con wells (P < 0.001 
for both the apical and basolateral directions). Both 
unstimulated secretion of IL-8, in Con wells, and stimu-
lated secretion, in wells treated with Sal, were greater 
in the basolateral than in the apical direction (P < 
0.05 for control wells and P < 0.001 for wells treated 
with Sal). Treatment with both BL isolates (BL and 
BL2) decreased basal secretion of IL-8 when compared 
with control wells (P < 0.05). Pretreatment with each 
Bacillus isolate followed by challenge with Sal reduced 
Sal-induced IL-8 secretion in both the apical and ba-
solateral compartments compared with wells receiving 
only Sal (P < 0.001; except for BS3 apical, P < 0.01).
Effect of Bacillus Bacteria on Invasion  
of Sal into IPEC-J2 Cells
Plate counts of Sal from lysates of cells preexposed to 
Bacillus spp. (BL+Sal, BS1+Sal, and BS3+Sal) were 
similar to plate counts from cells treated only with Sal 
(Figure 2). However, colonies of Sal that could be isolat-
ed from epithelial cell lysates in the BL2+Sal treatment 
were reduced compared with Sal alone (P < 0.001).
Presence of Bacitracin in Media
Our original intent was to evaluate bacitracin in me-
dia at the conclusion of the incubation after addition 
of Sal. Unfortunately, those media were discarded and 
only the media recovered at the conclusion of the study 
were evaluated for the presence of bacitracin. Bacitra-
cin could be detected only in media from wells that 
had previously contained BL2 and BL2+Sal (Figure 
Figure 1. Polarized secretion of IL-8 from confluent porcine IPEC-
J2 intestinal epithelial cells. Secretion into the apical chamber is rep-
resented by the shaded bars, whereas secretion into the basolateral 
chamber is represented by the solid bars. Bars represent the mean ± 
SEM of 12 replicate wells per treatment. Treatments included a con-
trol (Con) with media alone, or 17 h apical incubation with 108 cfu/
well of Bacillus licheniformis American Type Culture Collection strain 
(BL), Bacillus subtilis commercial isolate 1 (BS1), B. licheniformis 
commercial isolate 2 (BL2), or B. subtilis commercial isolate 3 (BS3; 
top panel). Additional treatments (bottom panel) included all Bacil-
lus treatments exposed to 1 h of coculture with Salmonella enterica 
serovar Typhimurium (Sal) in the final hour of Bacillus incubation 
(BL+Sal, BS1+Sal, BL2+Sal, and BS3+Sal) or to S. enterica serovar 
Typhimurium for only 1 h (Sal). Media from the apical and basolateral 
compartments were removed and discarded. Cells were then washed, 
medium containing gentamicin was added, and the cells were returned 
to the incubator. After 4 h, the experiment was terminated and me-
dia from the apical and basolateral compartments were removed for 
determination of IL-8. For analysis of the data, effects of treatment 
(Trt), secretion direction (Dir), and their interaction were included 
in the model. The numbers above and below the bars represent com-
parisons among interaction means between and within the Con and 
Sal treatments: 1 vs. 2, apical Con vs. apical Sal, P < 0.001; 3 vs. 4, 
basolateral Con vs. basolateral Sal, P < 0.001; 5 vs. 6, apical Con vs. 
basolateral Con, P < 0.05; 7 vs. 8, apical Sal vs. basolateral Sal, P < 
0.001. Letters above and below the bars show comparisons between 
Con and other treatments (top panel) or between Sal and other treat-
ments (bottom panel) within apical and basolateral means (a vs. b, P 
< 0.001; a vs. c, P < 0.01).
Figure 2. Invasion of Salmonella enterica serovar Typhimurium 
(Sal) into polarized confluent porcine IPEC-J2 intestinal epithelial 
cells. Bars represent the mean ± SEM of 9 replicate wells per treat-
ment. Treatments included apical 108 cfu of Sal alone or 17-h apical 
incubation with 108 cfu/well of Bacillus licheniformis American Type 
Culture Collection strain (BL), Bacillus subtilis commercial isolate 1 
(BS1), B. licheniformis commercial isolate 2 (BL2), or B. subtilis com-
mercial isolate 3 (BS3), and then coculture with Sal during the final 
hour of Bacillus incubation. Media from the apical and basolateral 
compartments were removed and discarded. Cells were then washed, 
medium containing gentamicin was added, and the cells were returned 
to the incubator. After 5 h, the experiment was terminated. The IPEC-
J2 cells were lysed and the lysate was cultured overnight on tryptic soy 
agar for the presence of Sal. Colonies of Sal were reduced in BL2+Sal 
compared with Sal (a vs. b, P < 0.001). Trt = treatment.
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3). Concentrations of bacitracin were similar for BL2 
and BL2+Sal in both the apical and the basolateral 
direction.
Sal Sensitivity to Bacitracin
Bacterial growth was observed in all the wells treated 
with Sal regardless of the dose of bacitracin tested. The 
microplate assay was qualitative, meaning that as long 
as bacterial growth resulted in a minimum predeter-
mined level of absorbance, the level of bacitracin in 
the well failed to inhibit growth. It is possible that the 
greatest concentrations of bacitracin may have inhibit-
ed Sal growth, but that reduction would not have been 
detected based on the protocol we used.
DISCUSSION
Previous studies demonstrated that a common swine 
pathogen of the gastrointestinal tract, Sal, induced a 
proinflammatory response in the swine jejunal epithe-
lial cell line IPEC-J2, as evidenced by secretion of the 
neutrophil chemoattractant IL-8 (Skjolaas et al., 2006). 
Basolaterally polarized secretion of IL-8 has also been 
observed in epithelial cell lines from other species (Mc-
Cormick et al., 1993; Vijay-Kumar et al., 2008). Of 
particular relevance to the current study, we previously 
reported that secretion of IL-8 from a model swine gas-
trointestinal epithelium was reduced substantially by 
pretreatment with the ATCC 10716 strain of BL (Skjo-
laas et al., 2007). Although a wide range of inflamma-
tory mediators could have been evaluated in the cur-
rent study, we evaluated elaboration of IL-8 into the 
media owing to its well-documented role in attracting 
neutrophils to sites of mucosal inflammation.
In the current study, we sought to investigate Bacil-
lus strains of more direct relevance to the swine indus-
try to evaluate whether the antiinflammatory action 
observed with the laboratory strain could be extended 
to Bacillus bacteria found in direct-fed microbial prepa-
rations. For this, we turned to the feed additive BioPlus 
2B. This additive is commercialized for use not only 
in pigs, but also in broilers and turkeys. It contains 
BL [Deutsche Sammlung von Microorganismen und 
Zellkulturen (DSM) 5749] spores isolated from soil and 
B. subtilis (DSM 5750) spores isolated from soybean 
fermentation. BioPlus 2B contains at least 1.6 × 109 
spores/g of each Bacillus that are resistant to flavo-
mycin and zinc-bacitracin. This product is reported to 
improve general health, fertility, and BW gain in swine 
production systems (Alexopoulos et al., 2004; Jørgens-
en and Kürti, 2006).
Our effort to obtain Bacillus bacteria from the prod-
uct resulted in recovery of 3 isolates. The 16S rRNA 
genetic analysis revealed the presence of 1 BL (98.1%) 
and 2 B. subtilis (99.93 and 99.99%). This is generally 
consistent with publically accessible information con-
cerning the bacterial content of the product. However, 
the 2 B. subtilis we recovered (BS1 and BS3) differed 
by only 4 bases, and 2 of those bases were found at the 
extremity of the sequence. The information provided 
by the feed additive manufacturer indicated that the 
product contained equal amounts of spores from BL 
and B. subtilis. It could be that BS1 and BS3 are, in 
fact, the same B. subtilis, but given the slight difference 
underlined by the RNA analysis, we elected to evaluate 
the organisms separately.
In the current investigation, we again confirmed that 
the isolate of Sal that we have used in many in vivo 
(Balaji et al., 2000; Burkey et al., 2004; Fraser et al., 
2007) and in vitro studies (Skjolaas et al., 2006, 2007) 
stimulated polarized secretion of IL-8 from IPEC-J2 
cells. This effect has been thoroughly documented in 
this swine-derived cell line (Schierack et al., 2006) and 
in cell lines from other species (Eckmann et al., 1993; 
Figure 3. Concentration of bacitracin from confluent porcine IP-
EC-J2 intestinal epithelial cells. Accumulation in the apical chamber is 
represented by the shaded bars, whereas secretion into the basolateral 
chamber is represented by the solid bars. Bars represent the mean ± 
SEM of 12 replicate wells per treatment. Treatments included a con-
trol (Con) with media alone or a 17-h apical incubation with 108 cfu/
well of Bacillus licheniformis American Type Culture Collection strain 
(BL), Bacillus subtilis commercial isolate 1 (BS1), B. licheniformis 
commercial isolate 2 (BL2), or B. subtilis commercial isolate 3 (BS3; 
top panel). Additional treatments (bottom panel) included all Bacil-
lus treatments exposed to 1 h of coculture with Salmonella enterica 
serovar Typhimurium (Sal) in the final hour of Bacillus incubation 
(BL+Sal, BS1+Sal, BL2+Sal, and BS3+Sal) or to S. enterica serovar 
Typhimurium for only 1 h (Sal). Media from the apical and basolateral 
compartments were removed and discarded. Cells were then washed, 
medium containing gentamicin was added, and the cells were returned 
to the incubator. After 5 h, the experiment was terminated and media 
from the apical and basolateral compartments were removed for deter-
mination of concentration of bacitracin. Bacitracin was not detectable 
(ND) in media from treatments other than BL2 and BL2+Sal.
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McCormick et al., 1993). Of relevance to the major 
focus of the current study, we again observed that the 
ATCC BL isolate completely inhibited Sal-induced 
secretion of IL-8 from IPEC-J2. Similarly, all isolates 
from the commercial feed additive behaved similarly 
to the ATCC BL isolate in blunting both apical and 
basolateral secretion of IL-8, although BS3 was some-
what less effective compared with the other strains. Of 
interest, both strains of BL (BL and BL2) even reduced 
basal IL-8 secretion from cells not stimulated with Sal. 
We had observed a similar effect previously, but only 
with Lactobacillus reuteri (Skjolaas et al., 2007).
One hypothesis to explain the ability of Bacillus bac-
teria to affect inflammatory signaling from enterocytes 
in vitro was that Bacillus prevented Sal from attach-
ing and invading into the cell monolayer. To evaluate 
this possibility, we cultured lysates of IPEC-J2 after 
exposure to Bacillus. When compared with Sal, only 
BL2+Sal reduced colonies of Sal that could be recul-
tured out of IPEC-J2 lysates. Although graphically, 
the reduction does not appear to be substantial on a 
logarithmic scale, it likely indicates a marked decline 
in the number of Sal breaching the epithelial barrier in 
the BL2+Sal treatment. Although this reduction may 
be related to other factors (discussed below), it does 
not explain the general ability of Bacillus to reduce se-
cretion of IL-8 under these experimental circumstances 
because BL, BS1, and BS3 all reduced IL-8 without 
affecting invasion.
Among other secondary secretory components, Bacil-
lus bacteria, including the ATCC BL isolate, are known 
to produce the polypeptide antibiotic bacitracin (Konz 
et al., 1997). We hypothesized that the ability of Ba-
cillus bacteria, particularly BL, to affect Sal invading 
IPEC-J2 cells may simply be related to their ability to 
produce bacitracin. As noted previously, our intent was 
to measure bacitracin in media collected at the conclu-
sion of the bacterial incubation. Unfortunately, those 
media were discarded and only media collected at the 
conclusion of the study were available for determina-
tion of bacitracin content.
Bacitracin was detected only in media from wells 
that had contained BL2, both in the presence and ab-
sence of Sal. In our antibiotic sensitivity tests, bacitra-
cin failed to prevent Sal growth at concentrations up to 
20 μg/mL. Because we did not measure bacitracin at 
the conclusion of the bacterial incubation, we cannot 
say with absolute certainty that other BL2 or other 
bacilli produced bacitracin at quantities sufficient to 
affect the viability of Sal in our cultures. Thus, we must 
limit our interpretation and discussion here to account 
for the residual presence of bacitracin in the absence of 
Bacillus organisms and after thorough washing of wells. 
Key to our interpretation, we noted the gross appear-
ance of biofilm associated with cultures of BL2 as we 
gained early experience growing the isolate. Bacillus 
bacteria are well-known producers of a variety of me-
tabolites, including surfactin. Bacillus subtilis, for ex-
ample, is known to produce a large array of secondary 
metabolites, such as mycosubtilin, iturin, and surfactin 
(Arima et al., 1968; Stein, 2005; Seydlova and Svobo-
dova, 2008). Surfactin is a lipopeptide antibiotic and 
a powerful biosurfactant (Singh and Cameotra, 2004; 
Rodrigues et al., 2006; Nagorska et al., 2007). Surfac-
tin, among its many properties, exhibits antimicrobial 
activities. Therefore, we suggest that BL2-produced 
biofilm that was resistant to washing after bacterial 
incubation could likely have been the source of passive 
evolution of bacitracin in the media in the absence of a 
direct source from Bacillus bacteria. Whether sufficient 
bacitracin was produced to affect survival of Sal in the 
BL2+S treatment cannot be determined from the cur-
rent data.
Finally, we feel it is important to consider whether 
the effects of Bacillus on Sal-induced IL-8 secretion we 
have observed here and previously (Skjolaas et al., 2007) 
have physiological relevance. Perhaps it could be that 
these effects might simply be an artifactual consequence 
of the pretreatment with Bacillus bacteria exhausting 
the nutrients in the media, leaving the cells less capable 
of secreting IL-8. On one hand, the production of baci-
tracin is generally associated with the early stages of 
sporulation in BL (Bernlohr and Novelli, 1959), and 
this, coupled with the obvious acidity (yellowing) that 
developed in the media by the time Sal were added, 
might support such a conclusion. On the other hand, 
under identical experimental conditions, a lactic acid-
producing bacteria, L. reuteri, produced substantial 
acidity in the media, but this condition alone failed to 
reduce the ability of Sal to stimulate IL-8 secretion from 
IPEC-J2 (Skjolaas et al., 2007). Assuming our findings 
have relevance to the function of Bacillus-containing 
feed additives within the gastrointestinal tract, an im-
portant question that remains relates to the ability of 
these bacteria, or any direct-fed microbial, to colonize 
the gut in sufficient numbers to affect the interaction 
of the epithelium with enteropathogens to explain the 
reported benefits of probiotic bacteria.
Results of the current studies indicate that Bacillus 
bacteria, at least B. subtilis and BL, have the ability to 
intervene in secretion of the neutrophil chemoattractant 
IL-8 from swine intestinal epithelial cells. This effect on 
chemokine secretion by gastrointestinal epithelial cells 
in vitro could not be explained by reduced invasion of 
epithelial cells by Sal.
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